ACCRU News & Releases – October 12, 2018
ACCRU leadership is now collaborating with Quorum to provide a central institutional review board (IRB) option for network members participating in ACCRU trials.
“We are excited to offer our members the opportunity to use Quorum as a central IRB for certain ACCRU studies, with the goal of streamlining the study activation process. This collaboration is part of our ongoing efforts to improve clinical trial administration processes so that our members can activate and enroll patients on ACCRU trials more rapidly,” says Tanios Bekaii-Saab, M.D., interim chair, ACCRU.
Information about Quorum central IRB services will be included in ACCRU study-specific documents.